exenatide glp 1 GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus GLP-1 receptor agonist exenatide uncouples

[DOI] [PMC free article] [PubMed] [Google Scholar] 185.Pivetta B, Chen L, Nagappa M, et al

Gregory Westcott, Beth Israel Deaconess Medical Center and Harvard Medical School, United States Updates Copyright 2023 Muller, Stenvers, Malekzadeh, Holleman, Painter and Siegelaar

Synthetic small molecule GLP-1 secretagogues prepared by means of a three-component indole annulation strategy

While various studies have examined the effects of GLP-1 agonists in obesity, two notable phase 3 trials are worth highlighting in this context

Objective To assess whether GLP-1 RA therapy is associated with improved clinical outcomes in patients with IIH compared with conventional therapies